Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Long-Term Investments (2017 - 2025)

Dr Reddys Laboratories (RDY) has 7 years of Long-Term Investments data on record, last reported at $12.8 million in Q1 2024.

  • For Q1 2024, Long-Term Investments changed N/A year-over-year to $12.8 million; the TTM value through Mar 2024 reached $12.8 million, changed N/A, while the annual FY2024 figure was $12.8 million, 59.91% up from the prior year.
  • Long-Term Investments reached $12.8 million in Q1 2024 per RDY's latest filing, down from $56.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $56.6 million in Q1 2022 and bottomed at $676378.1 in Q1 2020.
  • Average Long-Term Investments over 4 years is $28.9 million, with a median of $29.1 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: crashed 98.06% in 2020, then surged 6605.58% in 2021.
  • A 4-year view of Long-Term Investments shows it stood at $676378.1 in 2020, then soared by 6605.58% to $45.4 million in 2021, then rose by 24.88% to $56.6 million in 2022, then tumbled by 77.49% to $12.8 million in 2024.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $12.8 million in Q1 2024, $56.6 million in Q1 2022, and $45.4 million in Q1 2021.